Our study identified circ_0084904 as a novel oncogenic driver in CC depending on the modulation of the miR-802/MAL2 axis, establishing the notion that silencing of circ_0084904 might represent a promising targeted therapy for CC.
The novel circ_0084904/miR-802/MAL2 axis promotes the development of cervical cancer.